Stroke was the fifth leading cause of death in the United States in 2021, and cost U.S. residents approximately $56.2 billion during 2019-2020. During 2006-2010, self-reported stroke prevalence among noninstitutionalized adults had a relative decrease of 3.7%. Data from the Behavioral Risk Factor Surveillance System were used to analyze age-standardized stroke prevalence during 2011-2022 among adults aged ≥18 years. From 2011-2013 to 2020-2022, overall self-reported stroke prevalence increased by 7.8% nationwide. Increases occurred among adults aged 18-64 years; females and males; non-Hispanic Black or African American (Black), non-Hispanic White (White), and Hispanic or Latino (Hispanic) persons; and adults with less than a college degree. Stroke prevalence was higher among adults aged ≥65 years than among younger adults; among non-Hispanic American Indian or Alaska Native, non-Hispanic Native Hawaiian or Pacific Islander, and Black adults than among White adults; and among adults with less than a high school education than among those with higher levels of education. Stroke prevalence decreased in the District of Columbia and increased in 10 states. Initiatives to promote knowledge of the signs and symptoms of stroke, and the identification of disparities in stroke prevalence, might help to focus clinical and programmatic interventions, such as the Million Hearts 2027 initiative or the Paul Coverdell National Acute Stroke Program, to improve prevention and treatment of stroke.

中文翻译：

---

中风患病率 - 行为风险因素监测系统，美国，2011-2022 年。


中风是 2021 年美国第五大死亡原因，2019-2020 年期间给美国居民造成了约 562 亿美元的损失。 2006年至2010年期间，非收容成年人自我报告的卒中患病率相对下降了3.7%。行为危险因素监测系统的数据用于分析 2011 年至 2022 年 18 岁以上成年人中年龄标准化卒中患病率。从2011-2013年到2020-2022年，全国范围内总体自我报告的卒中患病率增加了7.8%。 18-64岁的成年人中出现增加；女性和男性；非西班牙裔黑人或非裔美国人（黑人）、非西班牙裔白人（白人）以及西班牙裔或拉丁裔（西班牙裔）人；以及大学学历以下的成年人。 ≥65 岁成年人的中风患病率高于年轻人；非西班牙裔美洲印第安人或阿拉斯加原住民、非西班牙裔夏威夷原住民或太平洋岛民以及黑人成年人中的比例高于白人成年人；高中以下学历的成年人的比例高于受教育程度较高的成年人。哥伦比亚特区的中风患病率有所下降，而 10 个州的中风患病率有所上升。促进对中风体征和症状的了解以及确定中风患病率差异的举措可能有助于集中临床和规划干预措施，例如“百万之心 2027”倡议或保罗·科德尔国家急性中风计划，以改善预防和治疗治疗中风。